Resveratrol inhibits expression and binding activity of the monocyte chemotactic protein-1 receptor, CCR2, on THP-1 monocytes
- 14 May 2007
- journal article
- research article
- Published by Elsevier BV in Atherosclerosis
- Vol. 195 (1), e125-e133
- https://doi.org/10.1016/j.atherosclerosis.2007.03.039
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Resveratrol, a Polyphenolic Phytostilbene, Inhibits Endothelial Monocyte Chemotactic Protein-1 Synthesis and SecretionJournal of Vascular Research, 2006
- Increased expression levels of monocyte CCR2 and monocyte chemoattractant protein-1 in patients with diabetes mellitusBiochemical and Biophysical Research Communications, 2006
- Inhibition of Cyclic Strain-Induced Endothelin-1 Gene Expression by ResveratrolHypertension, 2003
- Homocysteine stimulates the expression of monocyte chemoattractant protein-1 receptor (CCR2) in human monocytes: possible involvement of oxygen free radicalsBiochemical Journal, 2001
- Oxidized LDL reduces monocyte CCR2 expression through pathways involving peroxisome proliferator–activated receptor γJCI Insight, 2000
- Resveratrol inhibits copper ion‐induced and azo compound‐initiated oxidative modification of human low density lipoproteinIUBMB Life, 1999
- Effects of 17β-estradiol and progesterone on migration of human monocytic THP-1 cells stimulated by minimally oxidized low-density lipoprotein in vitroCardiovascular Research, 1997
- Vasorelaxing activity of resveratrol and quercetin in isolated rat aortaGeneral Pharmacology: The Vascular System, 1996
- Alcoholic beverage choice and risk of coronary artery disease mortality: Do red wine drinkers fare best?The American Journal of Cardiology, 1993
- Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wineThe Lancet, 1993